- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/08 - AntiepilepticsAnticonvulsants
Patent holdings for IPC class A61P 25/08
Total number of patents in this class: 2785
10-year publication summary
|
68
|
125
|
197
|
180
|
213
|
251
|
202
|
182
|
224
|
68
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| GW Research Limited | 147 |
103 |
| Jazz Pharmaceuticals Research UK Limited | 250 |
73 |
| Xenon Pharmaceuticals Inc. | 194 |
47 |
| Taisho Pharmaceutical Co., Ltd. | 860 |
43 |
| The Regents of the University of California | 20534 |
39 |
| Praxis Precision Medicines, Inc. | 218 |
34 |
| Sage Therapeutics, Inc. | 338 |
33 |
| Takeda Pharmaceutical Company Limited | 2718 |
32 |
| Zogenix International Limited | 75 |
29 |
| Katholieke Universiteit Leuven | 1253 |
27 |
| Hoffmann-La Roche Inc. | 3686 |
25 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 184 |
25 |
| F. Hoffmann-La Roche AG | 7835 |
22 |
| Janssen Pharmaceutica N.V. | 3233 |
21 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3334 |
20 |
| Centre National de La Recherche Scientifique | 10865 |
17 |
| The Johns Hopkins University | 5819 |
17 |
| Otsuka Pharmaceutical Co., Ltd. | 1504 |
17 |
| Sumitomo Dainippon Pharma Co., Ltd. | 211 |
16 |
| Daiichi Sankyo Company, Limited | 1887 |
15 |
| Other owners | 2130 |